Cytomegalovirus reactivation following hematopoietic stem cell transplantation | Zendy

Sanjeev Sharma | Zendy; Suman Kumar | Zendy; Narendra Agrawal | Zendy; Lavleen Singh | Zendy; Anjan Mukherjee | Zendy; Tulika Seth | Zendy; Pravas Mishra | Zendy; Sandeep Mathur | Zendy; Lalit Dar | Zendy; Manoranjan Mahapatra | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Cytomegalovirus reactivation following hematopoietic stem cell transplantation

Author(s) -

Sanjeev Sharma,

Suman Kumar,

Narendra Agrawal,

Lavleen Singh,

Anjan Mukherjee,

Tulika Seth,

Pravas Mishra,

Sandeep Mathur,

Lalit Dar,

Manoranjan Mahapatra

Publication year - 2013

Publication title -

the journal of infection in developing countries

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.322

H-Index - 49

eISSN - 2036-6590

pISSN - 1972-2680

DOI - 10.3855/jidc.2947

Subject(s) - cytomegalovirus , transplantation , hematopoietic stem cell transplantation , medicine , stem cell , human cytomegalovirus , immunology , valganciclovir , gastroenterology , incidence (geometry) , betaherpesvirinae , herpesviridae , biology , viral disease , virus , ganciclovir , physics , optics , genetics

There is a high prevalence of cytomegalovirus (CMV) seropositivity in developing countries. An apparent risk of CMV reactivation increases following hematopoeitic stem cell transplantation. With effective surveillance and timely treatment using anti-viral therapy, morbidity and mortality associated with CMV reactivation can be reduced.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research